Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jordan Smith (NPI 1013514553)

Field	Value
Entity Type	Individual
Organization	Jordan Smith
Address	2550 Flowood Dr Ste 300
City	Flowood
State	MS
ZIP	39232
Taxonomy	Family Nurse Practitioner
NPI Enumerated	October 7, 2020

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider is effectively single-payer in the available data: lifetime Medicare revenue is $1.1M and there is no Medicaid billing on file, so Medicaid does not contribute to this provider’s documented public-payer volume. Analysts should treat Medicare activity as the sole source of federal claims when modeling payer mix or estimating public-coverage patient volume for this NPI.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 66.3% of the provider's total Medicare revenue, indicating reliance on a small set of drugs/services for most Medicare receipts. Those dominant codes are high-cost drug administrations (see J1602, J0129, J1745) rather than routine office visits, which shapes the business model toward infusion/biologic administration.

The code mix indicates a specialty infusion/biologic administration operation under a Family Nurse Practitioner taxonomy: the largest revenue drivers are J1602, J0129, and J1745 (golimumab, abatacept, infliximab), together producing the majority of Medicare revenue. Substantial claim volumes for these injectable biologics and supporting chemotherapy/infusion codes (96413, 96401, 96415) suggest episodic infusion treatments are the core service line rather than primary-care office-based evaluation and management.

Competitive standing on the top drug codes is mixed: for J1602 the provider ranks #106 of 1041 (90th percentile), which positions them as a relatively high-volume national participant for that drug; by contrast J0129 ranks #700 of 1221 (43th percentile) and J0717 and J3262 sit in lower percentiles (20th and 17th respectively), indicating more modest or typical participation for those agents. Overall, the provider is a notable but not dominant national player on at least one high-revenue biologic and a routine-volume participant on several others.

Routine E/M and lab services appear secondary to infusion work. 99213 generated $52.5K (4.5% of Medicare revenue) but is flagged as an “extreme outlier, far above typical national volume” (rank #4898 of 457151, 99th percentile), implying unusually high office-visit billing relative to peers even though it represents a small share of total revenue. Multiple common lab CPTs (80076, 86140, 85652 and others) show high-percentile ranks (mostly in the 90s), indicating frequent on-site or ordered lab testing that supports infusion/therapy monitoring.

Infusion and chemotherapy administration codes appear consistently used: 96413 ($32K, 2.7% of Medicare revenue) ranks in the 89th percentile nationally and other chemotherapy administration/add-on codes (96401, 96415) also appear among top line items. This pattern reinforces that the practice performs a nontrivial volume of infusion or injectable therapy sessions rather than exclusively dispensing single-dose injections.

Tenure is moderate: the NPI was enumerated on 2020-10-07 (~6 years ago). With about six years of active enrollment, the provider has built a concentrated biologic/infusion revenue stream in a relatively short practice lifespan, which is relevant when evaluating growth or market entry timing.

Given the absence of Medicaid billing on file, payers evaluating network inclusion or risk should recognize that this provider’s public-payer exposure is concentrated in Medicare biologics and infusion services; commercial or self-pay activity is not visible here and would need to be corroborated with additional data sources if relevant to network or contracting decisions.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1602	Injection, golimumab, 1 mg, for intravenous use	36,310	$10	$399.5K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	7,200	$30	$237.6K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,340	$30	$138.8K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	25,600	$1	$102.4K
J3262	Injection, tocilizumab, 1 mg	18,600	$10	$93K
J0897	Injection, denosumab, 1 mg	3,660	$20	$65.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,120	$50	$52.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	460	$70	$32K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	1,060	$10	$8.5K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	1,050	$10	$8.4K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Mississippi Distribution

Jordan Smith — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Mississippi

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	7	10	8,840	$30	$367.2K
J3262	7	10	55,080	$1	$299.4K
J1602	3	10	18,250	$10	$265.7K
J0717	7	10	36,000	$1	$144.1K
J0897	45	110	3,030	$20	$95.7K
J1745	4	20	2,470	$30	$87.5K
96413	18	70	100	$80	$22.6K
99213	83	4,000	100	$50	$10.3K
96401	19	60	80	$50	$7.1K
96415	18	40	130	$20	$2.7K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jordan Smith, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sharon Hong	MS	Rheumatology Physician	$2.1M	$0
Teresa Crout	MS	Rheumatology Physician	$1.1M	$0

Nearby Providers

Other providers in the same ZIP code as Jordan Smith, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rem East LLC	MS	Community/Behavioral Health Agency	$0	$97M
Love And Faith Personal Care And Respite Services	MS	Home Health Agency	$0	$24.3M
M-d Medical Services, Inc.	MS	Parenteral & Enteral Nutrition Supplies (DME)	$0	$18M
River Oaks Hospital LLC	MS	General Acute Care Hospital	$0	$16.6M
National Seating & Mobility, Inc.	MS	Durable Medical Equipment & Medical Supplies	$0	$12.5M
Madison Physician Surgery Center, LLC	MS	Ambulatory Surgical Clinic/Center	$12.3M	$30.3K
Mobility Medical Inc	MS	Oxygen Equipment & Supplies (DME)	$0	$10.4M
Prescribed Pediatric Extended Care, Inc	MS	Medically Fragile Infants and Children Day Care	$0	$9.5M
Women's Health Associates, PLLC	MS	Obstetrics & Gynecology Physician	$0	$9.4M
Rem East LLC	MS	Developmentally Disabled Services Day Training Agency	$0	$7.8M

Jordan Smith — Billing Profile & Reimbursement Data

Sign up for Jordan Smith — Billing Profile & Reimbursement Data policy alerts

Jordan Smith — Billing Profile & Reimbursement Data

Sign up for Jordan Smith — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References